PGxAlly began with a simple observation: medication decisions drive a significant share of healthcare outcomes and costs, yet most opportunities to improve those decisions never reach action. We set out to fix the part everyone else leaves undone, execution.
We started in pharmacogenomics, helping providers personalize medication therapy to a patient's genetics. What we learned was bigger than PGx: the hard part was never identifying the opportunity. It was getting it acted upon.
So we built the layer that closes that gap. Today, PGxAlly combines pharmacists, technology, laboratory partnerships, and workflow integration to help healthcare organizations close medication-related gaps at scale. Precision medicine is one of six clinical modules today, and the place our story began.
Where we started. Genetics-guided medication therapy.
Identifying opportunities was never the hard part. Execution was.
Pharmacists and technology that turn insight into completed action.
Software, dashboards, and analytics are replaceable. A national pharmacist network that can actually execute is not.
An identified gap that never closes returns nothing. We measure ourselves on completed actions and outcomes.
Every program returns measurable results the buyer can defend at renewal and in value-based contracts.
Bring us the opportunities you already identify. We'll show you how we close them.